scholarly journals Molecular identification and phylogeny of bovine herpesvirus-1 (BoHV-1) from cattle associated with respiratory disorders and death in Turkey

2020 ◽  
Vol 76 (06) ◽  
pp. 6393-2020
Author(s):  
HARUN ALBAYRAK ◽  
CUNEYT TAMER ◽  
EMRE OZAN ◽  
BAHADIR MUFTUOGLU ◽  
HAMZA KADI ◽  
...  

This study aimed to investigate the presence of bovine herpesvirus 1 by molecular techniques in two cases of respiratory disease in beef cattle, reported from Amasya Province of Turkey in 2018. Nasal swab and lung tissue samples were taken. The presence of bovine herpesvirus-1 (BoHV-1) was confirmed by the PCR method using glycoprotein B (gB) gene-specific primers, and then the isolates were also subjected to partial sequencing. The results of the phylogenetic analysis revealed that the two new isolates in Turkey belonged to the same subclade as subtype 1.1 of BoHV-1, and both also had a 100% nucleotide (nt) homology with the Cooper reference strain of BoHV-1. These findings can enrich the gB sequence content data for BoHV-1 found in GenBank regarding Turkey.

2019 ◽  
Vol 97 (Supplement_1) ◽  
pp. 16-17
Author(s):  
Hannah A Seiver ◽  
Kendall L Samuelson ◽  
Richard D Posey ◽  
Dexter J Tomczak ◽  
Taylor M Smock ◽  
...  

Abstract The study objective was to determine the effect of a DNA immunostimulant on recrudescence of bovine herpesvirus-1 (BHV-1) after dexamethasone challenge in beef cattle. It was hypothesized that the DNA immunostimulant would mitigate stress-induced immunosuppression; thereby, reducing the incidence of BHV-1 recrudescence. Steers (n = 10) and heifers (n = 10; initial BW = 489 kg ± 57 kg) were stratified by pre-existing BHV-1 antibody titer, sex and initial BW and randomly assigned to treatment (n = 4 pens/treatment; 2 or 3 animals/pen). All calves were administered 40 mg of dexamethasone i.v. at 0600 h from d 0 to 2, 166-d subsequent to BHV-1 challenge with 1.0 × 108 plaque-forming units per nostril. On d 1, calves were administered treatments consisting of 2 mL i.m. of DNA immunostimulant (Zelnate; ZEL) or sterile saline (CON). Once daily (0600) from d 0 to 12, a whole blood was obtained via jugular venipuncture for complete blood count (CBC) analysis and nasal swabs were collected to determine BHV-1 prevalence via virus isolation testing. A repeated measures mixed model was used to test the effect of treatment, day and their interaction for CBC variables. There was a treatment × day interaction for eosinophils (P = 0.02) and percent eosinophils (P = 0.03). Eosinophils were greater (P < 0.01) for ZEL on d 3 and 6 post-dexamethasone challenge. On d 11 and 12, eosinophils for CON rebounded such that their concentration was greater than ZEL (P < 0.01). Lymphocytes, neutrophil and monocyte concentration did not differ (P ≥ 0.44); however, a day effect (P ≤ 0.01) existed such that each variable increased transiently after dexamethasone challenge. All cattle had BHV-1 present in a nasal swab sample on at least one sample day, with prevalence of BHV-1 in nasal swab samples being greatest on d 5 (80% positive; P = 0.01). However, no treatment differences were detected for BHV-1 prevalence in this study. The DNA immunostimulant altered eosinophil concentrations but did not mitigate BHV-1 recrudesce after dexamethasone challenge


2021 ◽  
Vol 41 (01) ◽  
pp. 163-165
Author(s):  
Hammad Ur Rehman

The study was aimed to isolate BoHV-1 circulating in Lahore, Pakistan and its genetic characterization. For this purpose, blood samples were collected from different areas of district Lahore through convenient sampling technique. Out of 100 blood samples, 69 (69%, 95% CI: 58.86-77.66) samples have shown seropositivity against BoHV-1 through ELISA. For the isolation of BoHV-1, nasal swab samples were collected from 69 seropositive cattle and buffalo. Out of 69 nasal swab samples, only 6 samples have shown the visible cytopathic effect and confirmed through nested polymerase chain reaction by targeting glycoprotein B (gB). The phylogenetic analysis showed that local isolates showed similarity to subtype 1.1 of BoHV-1 and had 99-100% homology with Cooper strain. It was concluded that BoHV-1.1 is being circulating in Pakistan and further studies are needed which will help for clear understanding of virus characterization and development of effective local vaccine


2016 ◽  
Vol 9 (12) ◽  
pp. 1364-1369 ◽  
Author(s):  
S. S. Patil ◽  
A. Prajapati ◽  
D. Hemadri ◽  
K. P. Suresh ◽  
G. S. Desai ◽  
...  

2019 ◽  
Vol 97 (Supplement_1) ◽  
pp. 40-41
Author(s):  
Hannah A Seiver ◽  
Kendall L Samuelson ◽  
Richard D Posey ◽  
Dexter J Tomczak ◽  
Taylor M Smock ◽  
...  

Abstract The study objective was to determine the effect of a DNA immunostimulant on recrudescence of bovine herpesvirus-1 (BHV-1) after dexamethasone challenge in beef cattle. It was hypothesized that the DNA immunostimulant would mitigate stress-induced immunosuppression; thereby, reducing the incidence of BHV-1 recrudescence. Steers (n=10) and heifers (n=10; initial BW = 489 kg ± 57 kg) were stratified by pre-existing BHV-1 antibody titer, sex and initial BW and randomly assigned to treatment (n=4 pens/treatment; 2 or 3 animals/pen). All calves were administered 40 mg of dexamethasone i.v. at 0600 h from d 0 to 2, 166-d subsequent to BHV-1 challenge with 1.0 × 108 plaque-forming units per nostril. On d 1, calves were administered treatments consisting of 2 mL i.m. of DNA immunostimulant (Zelnate; ZEL) or sterile saline (CON). Once daily (0600) from d 0 to 12, a whole blood was obtained via jugular venipuncture for complete blood count (CBC) analysis and nasal swabs were collected to determine BHV-1 prevalence via virus isolation testing. A repeated measures mixed model was used to test the effect of treatment, day and their interaction for CBC variables. There was a treatment × day interaction for eosinophils (P = 0.02) and percent eosinophils (P = 0.03). Eosinophils were greater (P < 0.01) for ZEL on d 3 and 6 post-dexamethasone challenge. On d 11 and 12, eosinophils for CON rebounded such that their concentration was greater than ZEL (P < 0.01). Lymphocytes, neutrophil and monocyte concentration did not differ (P ≥ 0.44); however, a day effect (P ≤ 0.01) existed such that each variable increased transiently after dexamethasone challenge. All cattle had BHV-1 present in a nasal swab sample on at least one sample day, with prevalence of BHV-1 in nasal swab samples being greatest on d 5 (80% positive; P = 0.01). However, no treatment differences were detected for BHV-1 prevalence in this study. The DNA immunostimulant altered eosinophil concentrations but did not mitigate BHV-1 recrudesce after dexamethasone challenge


2019 ◽  
Vol 24 (1) ◽  
pp. 34
Author(s):  
Dewi Noor Hidayati ◽  
Eko Agus Srihanto ◽  
Tri Untari ◽  
Michael Haryadi Wibowo ◽  
Koichi Akiyama ◽  
...  

Considering the increasing incidence of infectious bovine rhinotracheitis (IBR) in Indonesia, it was necessary to conduct a more in-depth study of bovine herpesvirus-1 (BHV-1) as the causative agent of IBR disease. Previous research reports indicate that the BHV-1 subtypes found in Indonesia are subtype 1.1. Currently, IBR field case detection in Indonesia still uses the serological method (ELISA), which has the potential to give false positive results and cannot explain the virus subtype. Other detection methods, such as viral isolation, take longer and require adequate resources. This study aimed to determine the BHV-1 subtypes of Indonesian isolates using molecular techniques. Nested PCR using two pairs of primers was successfully used to amplify the glycoprotein D (gD) gene. The gD gene fragment was cloned into the pGEM-T plasmid. Analysis of the gD gene sequence was subsequently carried out to determine the BHV-1 character of the Indonesian isolates. The results indicated that the isolates were different from the previous isolates, and had similarities (100%) with subtype 1.2 strain SP1777 and SM023.


1989 ◽  
Vol 63 (4) ◽  
pp. 1525-1530 ◽  
Author(s):  
J J Carter ◽  
A D Weinberg ◽  
A Pollard ◽  
R Reeves ◽  
J A Magnuson ◽  
...  

1982 ◽  
Vol 23 (4) ◽  
pp. 565-569
Author(s):  
C. Ek-Kommonen ◽  
P. Veijalainen ◽  
M. Rantala ◽  
E. Neuvonen

Sign in / Sign up

Export Citation Format

Share Document